Synopsis - PLoS ONE
... disease (NAFLD) are characterized by a spectrum of pathological conditions ranging from an early stage of inflammation and fibrosis up to more advanced disease conditions, such as hepatocellular carcinoma. The prevalence of NAFLD is between 10 and 25% of the population, with large differences in age ...
... disease (NAFLD) are characterized by a spectrum of pathological conditions ranging from an early stage of inflammation and fibrosis up to more advanced disease conditions, such as hepatocellular carcinoma. The prevalence of NAFLD is between 10 and 25% of the population, with large differences in age ...
molluscum contagiosum
... waxing their genital regions, to prevent further spread of lesions. Similarly, patients should be advised against squeezing molluscum spots, both due to risk of super-infection and also as the central plug is full of infectious virus which is easily spread to uninfected skin. ...
... waxing their genital regions, to prevent further spread of lesions. Similarly, patients should be advised against squeezing molluscum spots, both due to risk of super-infection and also as the central plug is full of infectious virus which is easily spread to uninfected skin. ...
Clostridium difficile Colitis
... times daily for 10 to 14 days. • Alternative: vancomycin 125 mg orally four times daily for 10 to 14 days First relapse Confirm diagnosis (see text) If symptoms are mild, conservative management may be appropriate If antibiotics are needed, repeat treatment as in initial episode ...
... times daily for 10 to 14 days. • Alternative: vancomycin 125 mg orally four times daily for 10 to 14 days First relapse Confirm diagnosis (see text) If symptoms are mild, conservative management may be appropriate If antibiotics are needed, repeat treatment as in initial episode ...
AFFIRM (Atrial Fibrillation Follow
... No loss to follow up ITT and Per-protocol analyses used, and sensitivity analysis performed Reporting Bias Outcomes assess rate of treatment failure, which was a surrogate parameter determined from a previous study by same authors, where they found that patients with treatment failure had high ...
... No loss to follow up ITT and Per-protocol analyses used, and sensitivity analysis performed Reporting Bias Outcomes assess rate of treatment failure, which was a surrogate parameter determined from a previous study by same authors, where they found that patients with treatment failure had high ...
file (Advanced Pharmaceutical Care: HIV)
... Patients with documented PCP and moderate-to-severe disease, as defined by room air pO2 <70 mm/Hg or arterial-alveolar O2 gradient >35 mm/Hg, should receive corticosteroids as early as possible, and certainly within 72 hours after starting specific PCP therapy. Alternative therapeutic regimens inclu ...
... Patients with documented PCP and moderate-to-severe disease, as defined by room air pO2 <70 mm/Hg or arterial-alveolar O2 gradient >35 mm/Hg, should receive corticosteroids as early as possible, and certainly within 72 hours after starting specific PCP therapy. Alternative therapeutic regimens inclu ...
AAAAI Session 1206 PID-what do I do with my patient
... 91phox Busulfan conditioning Early cell marking was 4-26%, decreased to 0.03-1.1% with partial resolution of infections in 2/3 patients ...
... 91phox Busulfan conditioning Early cell marking was 4-26%, decreased to 0.03-1.1% with partial resolution of infections in 2/3 patients ...
30-32 cold or flu - Professional Nursing Today
... complications of cold or ‘flu and require referral to the doctor. Medical history – Certain medications should be avoided in patients with heart disease, hypertension or diabetes. Patients with chronic bronchitis should be referred to their doctor if they have a bad cold or flu as it is often compli ...
... complications of cold or ‘flu and require referral to the doctor. Medical history – Certain medications should be avoided in patients with heart disease, hypertension or diabetes. Patients with chronic bronchitis should be referred to their doctor if they have a bad cold or flu as it is often compli ...
European Respiratory Society Annual Congress 2013
... Body: Background Current international guidelines recommend patients with smear positive pulmonary tuberculosis (TB) have respiratory isolation for 2 weeks after starting treatment. Identifying patients who are more likely to need prolonged periods of respiratory isolation can be used to reduce infe ...
... Body: Background Current international guidelines recommend patients with smear positive pulmonary tuberculosis (TB) have respiratory isolation for 2 weeks after starting treatment. Identifying patients who are more likely to need prolonged periods of respiratory isolation can be used to reduce infe ...
Low-level Laser Therapy
... •Continue Universal 2, 4 and 5 on a daily basis but able to take longer breaks in between treatments •Headaches have not returned, and together with taking Amitriptyline intermittently pain is manageable. In case of bad bouts of pain, increase of treatments restores the condition back to normal afte ...
... •Continue Universal 2, 4 and 5 on a daily basis but able to take longer breaks in between treatments •Headaches have not returned, and together with taking Amitriptyline intermittently pain is manageable. In case of bad bouts of pain, increase of treatments restores the condition back to normal afte ...
Research synopsis - Corey Smith QIMR
... The primary aim of this research is to develop an immunotherapy approach that can be used to treat patients with Epstein-Barr Virus (EBV) associated Hodgkin’s lymphoma, in particular patients who do not respond to current treatment strategies. Current therapies used to treat Hodgkin’s lymphoma are s ...
... The primary aim of this research is to develop an immunotherapy approach that can be used to treat patients with Epstein-Barr Virus (EBV) associated Hodgkin’s lymphoma, in particular patients who do not respond to current treatment strategies. Current therapies used to treat Hodgkin’s lymphoma are s ...
RHEUMATIC FEVER
... -This test allows rapid detection of GAS antigen, allowing the diagnosis of streptococcal pharyngitis to be made and antibiotic therapy to be initiated while the patient is still in physician’s office. -This test reportedly has a specificity of greater than 95% but a sensitivity of only 60-90%. Thus ...
... -This test allows rapid detection of GAS antigen, allowing the diagnosis of streptococcal pharyngitis to be made and antibiotic therapy to be initiated while the patient is still in physician’s office. -This test reportedly has a specificity of greater than 95% but a sensitivity of only 60-90%. Thus ...
Knowledge is the Enemy of Disease
... Adherence Score). Proportion of eligible patients with LDL < 100mg/dL in 12 months Adherence to lipid lowering agents prescription Adherence to antiplatelet therapy Adherence to ACE inhibitors prescription Adherence to high dose statins prescription LDL < 100mg/dL in 03, 06 and 12 months after ...
... Adherence Score). Proportion of eligible patients with LDL < 100mg/dL in 12 months Adherence to lipid lowering agents prescription Adherence to antiplatelet therapy Adherence to ACE inhibitors prescription Adherence to high dose statins prescription LDL < 100mg/dL in 03, 06 and 12 months after ...
Rheumatoid arthritis
... inflammation. However, NSAIDs do not reduce the long-term damaging effects of rheumatoid arthritis on the joints. • NSAIDs must be taken continuously and at a specific dose to have an antiinflammatory effect. Even at the correct doses, NSAIDs must usually be taken for several weeks before their effe ...
... inflammation. However, NSAIDs do not reduce the long-term damaging effects of rheumatoid arthritis on the joints. • NSAIDs must be taken continuously and at a specific dose to have an antiinflammatory effect. Even at the correct doses, NSAIDs must usually be taken for several weeks before their effe ...
Botulinum Toxin Therapy for the Upper Limb
... • Produces a short-term, and reversible, paralysis of the treated muscle • Effects are at their maximum after 10 to 12 days • Best evidence supports therapy after injection to maximise outcomes ...
... • Produces a short-term, and reversible, paralysis of the treated muscle • Effects are at their maximum after 10 to 12 days • Best evidence supports therapy after injection to maximise outcomes ...
Lymphomatous Meningitis - Lymphoma Research Foundation
... leptomeningitis, is a complication of lymphoma that occurs when ...
... leptomeningitis, is a complication of lymphoma that occurs when ...
Wegener`s Granulomatosis
... – Blocks cell division – Lymphopenia, mainly of B cells – Reduces antibody levels Daily PO vs. monthly IV show similar rate of remission. Daily PO has lower rate of relapse and higher rate of leukopenia/infection. (CYCLOPS trial) ...
... – Blocks cell division – Lymphopenia, mainly of B cells – Reduces antibody levels Daily PO vs. monthly IV show similar rate of remission. Daily PO has lower rate of relapse and higher rate of leukopenia/infection. (CYCLOPS trial) ...
Acute Decompensated Heart Failure
... patients that efficacious therapies have been demonstrated to date. Also referred to as diastolic HF. Several different criteria have been used to further define HFpEF. The diagnosis of HFpEF is challenging because it is largely one of excluding other potential noncardiac causes of symptoms suggesti ...
... patients that efficacious therapies have been demonstrated to date. Also referred to as diastolic HF. Several different criteria have been used to further define HFpEF. The diagnosis of HFpEF is challenging because it is largely one of excluding other potential noncardiac causes of symptoms suggesti ...
Challenges of Pharmacotherapy in the Treatment of Cystic Fibrosis Hanna Phan, Pharm.D.
... – Larger volume of distribution ...
... – Larger volume of distribution ...
A study for patients with AIDS-associated Kaposi`s sarcoma (KS
... sarcoma (KS). Velcade has been approved by the Food and Drug Administration (FDA) to treat other types of cancers and relapsed nonHodgkin’s lymphoma. This study is being done to find out if bortezomib is a safe and effective treatment for AIDS associated KS. There will be 24 participants in this stu ...
... sarcoma (KS). Velcade has been approved by the Food and Drug Administration (FDA) to treat other types of cancers and relapsed nonHodgkin’s lymphoma. This study is being done to find out if bortezomib is a safe and effective treatment for AIDS associated KS. There will be 24 participants in this stu ...
Pearls of Heart Failure Management
... patients with LV dysfunction ARB: Recommended to patients with LVEF <40% intolerant of ACE Beta Blockers: Shown effective in patients with HF with LVEF < 40% (start when euvolemic) Aldosterone blockade: Recommended in patients with NYHA class III or IV, LVEF <35% while receiving standard thera ...
... patients with LV dysfunction ARB: Recommended to patients with LVEF <40% intolerant of ACE Beta Blockers: Shown effective in patients with HF with LVEF < 40% (start when euvolemic) Aldosterone blockade: Recommended in patients with NYHA class III or IV, LVEF <35% while receiving standard thera ...
Поиск информации в английском научном
... because urinary calcium excretion depends upon factors such as age, sex, body weight, and diet. 4. Earlier studies verified that in MCN spontaneous remission is often seen. 5. Two mechanisms are responsible for the development of edema. 6. His blood sugar concentration was well controlled, and littl ...
... because urinary calcium excretion depends upon factors such as age, sex, body weight, and diet. 4. Earlier studies verified that in MCN spontaneous remission is often seen. 5. Two mechanisms are responsible for the development of edema. 6. His blood sugar concentration was well controlled, and littl ...
Significance of Controlling Hypertension in Patients
... • A direct relationship between volume status and BP has been recognized in patients with end-stage renal disease (ESRD) treated with dialysis. • An increase in the predialytic systolic BP may reflect hypervolemia. Data from the CLIMB study, which was obtained from 442 subjects in 32,295 sessions a ...
... • A direct relationship between volume status and BP has been recognized in patients with end-stage renal disease (ESRD) treated with dialysis. • An increase in the predialytic systolic BP may reflect hypervolemia. Data from the CLIMB study, which was obtained from 442 subjects in 32,295 sessions a ...
New Patient
... Patients with end stage renal disease (ESRD) have increased risk for progression to active TB disease • Risk is 10 – 25 times greater for persons with ESRD than in the general population ...
... Patients with end stage renal disease (ESRD) have increased risk for progression to active TB disease • Risk is 10 – 25 times greater for persons with ESRD than in the general population ...
Dyspepsia - Medicine is an art
... • A 43 y/o man, a taxi driver for long time, presented to the clinic today with the complaint of indigestion and upper abdominal pain. • These complaints initiated for last 3 months. Pain and indigestion are usually felt after heavy meals. Bowel movements are normal. He does not use NSAID, but he is ...
... • A 43 y/o man, a taxi driver for long time, presented to the clinic today with the complaint of indigestion and upper abdominal pain. • These complaints initiated for last 3 months. Pain and indigestion are usually felt after heavy meals. Bowel movements are normal. He does not use NSAID, but he is ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.